Karin Strobl

Dr. Karin Strobl is a Researcher at the Center for Biomedical Technology within the Faculty of Health and Medicine at the University for Continuing Education Krems. Her work focuses on developing and optimizing extracorporeal therapies, particularly regional citrate anticoagulation (RCA) protocols and bioartificial liver devices. She collaborates on clinical and preclinical studies involving hemodialysis, blood purification systems, and inflammation modulation.

Her research integrates biochemical, immunological, and engineering principles to address challenges in critical care medicine. Key themes include the role of ionized calcium/magnesium in RCA, citrate's impact on blood components, and device innovations for extracorporeal blood treatments. She has contributed to patent development for ion concentration measurement methods in anticoagulated blood.

Over 15 peer-reviewed articles since 2009 highlight her expertise in biomedical engineering applications for hemodialysis optimization, sepsis treatment, and bioartificial organ systems. Her work emphasizes translating laboratory findings into clinical anticoagulation protocols and monitoring technologies.